Stephen H Raymond1. 1. Department of Obstetrics and Gynaecology, Royal Hobart Hospital, Hobart, Tasmania, Australia. stephen.raymond@dhhs.tas.gov.au
Abstract
BACKGROUND: There is an impression of poor management of pregnancy sickness in Australia, specifically an apparent total reliance on metoclopramide, as a first-line choice. AIMS: To determine what management options are commonly used in by distributing a survey to Fellows and Diplomates of RANZCOG. METHODS: A web-based survey questionnaire distributed using an email list obtained from RANZCOG. RESULTS: A total of 495 responses were received (23%). For morning sickness, 89% of those replying give dietary advice frequently or always, and 70% prescribe metoclopramide frequently or always, whereas 59% advise pyridoxine and 10% prescribe doxylamine. For hyperemesis gravidarum, 86% prescribe metoclopramide and 75% ondansetron. CONCLUSIONS: Despite guidelines suggesting the use of antihistamines and dopamine agonists (phenothiazines), very few practitioners in this region make use of these in any numbers.
BACKGROUND: There is an impression of poor management of pregnancy sickness in Australia, specifically an apparent total reliance on metoclopramide, as a first-line choice. AIMS: To determine what management options are commonly used in by distributing a survey to Fellows and Diplomates of RANZCOG. METHODS: A web-based survey questionnaire distributed using an email list obtained from RANZCOG. RESULTS: A total of 495 responses were received (23%). For morning sickness, 89% of those replying give dietary advice frequently or always, and 70% prescribe metoclopramide frequently or always, whereas 59% advise pyridoxine and 10% prescribe doxylamine. For hyperemesis gravidarum, 86% prescribe metoclopramide and 75% ondansetron. CONCLUSIONS: Despite guidelines suggesting the use of antihistamines and dopamine agonists (phenothiazines), very few practitioners in this region make use of these in any numbers.
Authors: A Lupattelli; O Spigset; M J Twigg; K Zagorodnikova; A C Mårdby; M E Moretti; M Drozd; A Panchaud; K Hämeen-Anttila; A Rieutord; R Gjergja Juraski; M Odalovic; D Kennedy; G Rudolf; H Juch; A Passier; I Björnsdóttir; H Nordeng Journal: BMJ Open Date: 2014-02-17 Impact factor: 2.692